Co-Crystal of Rosiglitazone With Berberine Ameliorates Hyperglycemia and Insulin Resistance Through the PI3K/AKT/TXNIP Pathway <i>In Vivo</i> and <i>In Vitro</i>.

Front Pharmacol · 2022 · PMC9096649 · PMID 35571083

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

HOMA-IR value and plasma insulin concentration showed a decreasing trend ( Figure 2G ).

also in 47,180 other papers

an increasing trendno p-value reported

ISI values showed an increasing trend ( Figure 2H ), with the most significant in the RB-H group.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.